Article
Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis.
Expert opinion on drug safety - 1 Jan 2000
Biswas Mohitosh, Kali Sumaiya Khatun, Sarker Ashish Kumar, Sukasem Chonlaphat
Abstract excerpt
BACKGROUND: Clopidogrel's responsiveness may be affected by the paraoxonase-1 (PON1) enzyme encoded by the Q192R PON1 genetic variant. We aimed to determine the aggregated risk of MACEs associated with carrying Q192R PON1 genetic variant in patients taking clopidogrel. RESEARCH DESIGN AND METHODS: Different databases were searched systematically for eligible studies, and risk ratio (RR) was measured using RevMan...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
